Lawsuits Filed Over Digitek Recalls
Two weeks after Actavis issued a recall for its heart medication Digitek, or digoxin, the first lawsuits have been filed. Very little information has been made available on this recall other than that some tablets may be twice as thick and therefore contain twice the active ingredient as intended. It is unclear how many batches may be affected or which particular batches are affected.
In announcing the recall, Actavis said the double-strength tablets pose a risk of toxicity in patients with renal failure. The right quantity of digoxin can strengthen a feeble heart and calm fluttering heartbeats. Too much digoxin can make you nauseous, depress your blood pressure, slow down your heart rate or kill you.
Several reports of injury and illness have been reported in association with the recall. Plaintiffs are seeking damages over alleged injuries as well as compensation for monitoring for possible future health problems.